| Product Code: ETC9956797 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Tuberculosis Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Tuberculosis Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Tuberculosis Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United Kingdom (UK) Tuberculosis Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of tuberculosis in the United Kingdom |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in tuberculosis diagnostics leading to more accurate and efficient testing methods |
4.3 Market Restraints |
4.3.1 Limited healthcare budgets impacting the adoption of advanced tuberculosis diagnostic technologies |
4.3.2 Challenges in reaching remote or underserved populations for screening and testing |
4.3.3 Regulatory hurdles and compliance requirements affecting the development and commercialization of new diagnostic products |
5 United Kingdom (UK) Tuberculosis Diagnostics Market Trends |
6 United Kingdom (UK) Tuberculosis Diagnostics Market, By Types |
6.1 United Kingdom (UK) Tuberculosis Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Radiographic Method, 2021- 2031F |
6.1.4 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Diagnostic Laboratory Methods, 2021- 2031F |
6.1.5 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Nucleic Acid Testing, 2021- 2031F |
6.1.6 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Phage Assay, 2021- 2031F |
6.1.7 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Detection of Latent Infection (Skin Test & IGRA), 2021- 2031F |
6.1.8 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Cytokine Detection Assay, 2021- 2031F |
6.2 United Kingdom (UK) Tuberculosis Diagnostics Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 United Kingdom (UK) Tuberculosis Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
7 United Kingdom (UK) Tuberculosis Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Tuberculosis Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) Tuberculosis Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) Tuberculosis Diagnostics Market Key Performance Indicators |
8.1 Percentage increase in the number of tuberculosis cases diagnosed annually |
8.2 Adoption rate of new tuberculosis diagnostic technologies in healthcare facilities |
8.3 Average turnaround time for tuberculosis test results |
9 United Kingdom (UK) Tuberculosis Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Tuberculosis Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 United Kingdom (UK) Tuberculosis Diagnostics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United Kingdom (UK) Tuberculosis Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) Tuberculosis Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Tuberculosis Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here